have partnered to develop a novel, proprietary technology platform that leverages the power of natural ingredients and biotechnology. This platform is designed to enhance the efficacy of existing products and create new ones. The partnership between Beiersdorf and Macro Biologics, Inc.

They are a class of naturally occurring compounds found in plants and fungi. Amicidins are known for their potent anti-inflammatory and antioxidant properties. They have been shown to be effective in treating a wide range of skin conditions, including acne, eczema, psoriasis, and rosacea. Amicidins are also known for their ability to promote wound healing and reduce scarring.

“Through our collaboration with Macro Biologics, we further enhance Beiersdorf’s innovation power in line with our ‘Win with Care’ strategy, as well as our ambition to continue to lead in Climate Care,” emphasized Gitta Neufang, Ph.D., corporate senior vice president global R&D at Beiersdorf. ““We are excited to have found an outstanding partner in this promising field of antimicrobial peptides, who shares our visionary innovation drive…” Michael Bevilacqua, M.D., Ph.D., CEO and CSO of Macro Biologics, added, “… For Macro, this collaboration is a perfect fit, both from a research and business perspective. Beiersdorf’s deep expertise in product formulation, development and commercialization will empower Amicidins to improve the lives of people in a variety of settings. This partnership is based on shared principles, as we both strive to create sustainable value for people and the environment.”